This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Insiders Love Right Now

Sarepta Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Another stock that insiders are active in here is Sarepta Therapeutics ( SRPT), which is focused on the discovery and development of ribonucleic acid-based therapeutics for the treatment of rare and infectious diseases. Insiders are buying this stock into major strength, since shares are up sharply by 35% so far in 2013.

>>4 Stocks Under $10 to Trade for Breakouts

Sarepta Therapeutics has a market cap of $1.17 billion and an enterprise value of $973 million. This stock trades at a premium valuation, with a price-to-sales of 50.99 and a price-to-book of 12.40. Its estimated growth rate for this year is 36.6%, and for next year it's pegged at 12.6%. This is a cash-rich company, since the total cash position on its balance sheet is $156.18 million and its total debt is just $1.71 million.

A director just bought 3,500 shares, or about $114,000 worth of stock, at $32.68 per share.

From a technical perspective, SRPT is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock just came out of a nasty downtrend that took the stock from $47.35 to its recent low of $29.71 a share. Shares of SRPT have now entered a near-term uptrend, with the stock rebounding off that low of $29.71 and moving back above its 50-day moving average at $33.06 a share. That move has started to push SRPT within range of triggering a near-term breakout trade.

If you're bullish on SRPT, then look for long-biased trades as long as this stock is trending above its 200-day at $32.62 or above more support at $32, and then once it breaks out above some near-term overhead resistance at $35.49 a share high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 1.71 million shares. If that breakout hits, then SRPT will set up to re-test or possibly take out its next major overhead resistance levels at $39.12 to $42 a share.

5 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,291.30 +25.31 0.15%
S&P 500 2,009.04 -2.32 -0.12%
NASDAQ 4,572.4930 -20.9320 -0.46%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs